Health and Fitness Health and Fitness
Wed, November 10, 2010
Tue, November 9, 2010
Mon, November 8, 2010
Sun, November 7, 2010
Sat, November 6, 2010
Fri, November 5, 2010
Thu, November 4, 2010
Wed, November 3, 2010
Tue, November 2, 2010
Mon, November 1, 2010
Sat, October 30, 2010
Fri, October 29, 2010
Thu, October 28, 2010
Wed, October 27, 2010
Tue, October 26, 2010
Mon, October 25, 2010

Corgenix to Host Conference Call to Discuss First Quarter Results


//health-fitness.news-articles.net/content/2010/ .. rence-call-to-discuss-first-quarter-results.html
Published in Health and Fitness on Tuesday, November 2nd 2010 at 16:13 GMT by Market Wire   Print publication without navigation


DENVER--([ BUSINESS WIRE ])--Corgenix Medical Corporation (OTC BB: CONX), a worldwide developer and marketer of diagnostic test kits, will host a conference call on Thursday, November 11, 2010, at 4:00 p.m. EST to discuss the Companya™s financial and operating performance for its quarter ended September 30, 2010, and the status of the Companya™s product development and marketing activities.

Corgenix invites all those interested in hearing managementa™s discussion of the quarter results to join the call by dialing:

U.S. attendees: (800) 895-0198
International attendees: +1 785 424 1053
Conference code is: CORGENIX

A question-and-answer session will follow the presentation by Corgenix management.

A replay will be available for 30 days following the call by dialing (800) 695-0974 for U.S. participants and +1 402 220 1459 for international participants.

About Corgenix Medical Corporation

Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders, including the worlda™s only non-blood-based test for aspirin effect. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network and has significant experience advancing products through the FDA process. More information is available at [ www.corgenix.com ].


Publication Contributing Sources